USPTO serial 79271547
Serial No. 79271547
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 19, 2020
- Examiner
- ROBERTSON, DEIRDRE G
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79271547?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael Fedrick
Michael Fedrick Loza & Loza, LLP305 N. Second Ave. #127Upland, CA 91786-6064UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Association services, namely, promoting the commercial and business interests of haematologists in the field of further medical, scientific and business training | ACTIVE | — |
| 041 | Arranging, coordination and conducting of international, European and national events, conferences, congresses and symposiums for educational purposes; organisation of exhibitions for medical and scientific research for educational purposes | ACTIVE | — |
| 042 | Medical and scientific research in the field of haematology, in the field of diagnosing, treating and preventing diseases of the blood and of blood-forming organs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AOP Orphan Pharmaceuticals AG
- Other trademarks owned by AOP Orphan Pharmaceuticals AG
- Other trademarks owned by AOP Orphan Pharmaceuticals GmbH
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 19, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 18, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 26, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 11, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 21, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 21, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 19, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 19, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 3, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 3, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 12, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 19, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 16, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 15, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 15, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |